15 Delivery of Cancer Therapeutics

Monday, November 16, 2020: 8:00 AM - 9:00 AM
Food, Pharmaceutical & Bioengineering Division (15) (PreRecorded+)

Description:
This session highlights recent advances in methods and related technologies for delivery of therapeutics for cancer. This includes novel drug carriers, material design, and cell-based platforms.

Sponsor:
Engineering Fundamentals in Life Science
Co-chairs:
Xiaoping Bao Email: bao61@purdue.edu
Fan Zhang Email: zfan.eng@gmail.com


(15a) Synergy of an HDAC Inhibitor and Chemotherapy Delivered Via Lipid Nanoemulsions for TNBC
Debra Auguste


(15b) Mesenchymal Stem Cells Anchored with Thymidine Phosphorylase for Doxifluridine-Mediated Cancer Therapy
Ammar Ahmad Tarar, Esmael Alyami and Ching-An Peng


(15c) Calcium Phosphate-Polymeric Nanoparticle System for Co-delivery ofmicroRNA-21 Inhibitor and Doxorubicin
Vishnu Sriram, Mina Jafari and Joo-Youp Lee


(15e) Antibody Drug Nanoparticle Induces Synergistic Treatment Efficacies in Breast Cancer Cells
Muhammad Raisul Abedin and Sutapa Barua


(15f) ICAM-1 Nanobody Density on Liposomes Affects Selectivity for Triple Negative Breast Cancer and Inflamed Endothelium
Jacob Hebert and Debra Auguste


(15g) Peptide Engineering for Targeted, Intracellular Delivery of siRNA and Proteins (INVITED SPEAKER)
Millicent O. Sullivan
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>